Report an error

Spotted something inaccurate in “EV-Pembrolizumab Beats Cisplatin on Survival in Muscle-Invasive Bladder Cancer”? Tell us what’s wrong and we’ll check it against the original source.

Website

Send report Cancel

This form is for factual corrections. We read every report but cannot reply individually.